newsfilter
← Latest News
GlobeNewswire·

Codiak BioSciences Reports First Quarter 2022 Financial Results and Operational Progress

– Codiak to provide data from ongoing exoSTING™ and exoIL-12™ clinical trials in late 1H 2022 – – Anticipate first patients dosed in exoASO™-STAT6 Phase 1 clinical trial in 1H 2022 – – Data from preclinical engEx-AAV™ program to b